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Aims
To validate the English language Forgotten Joint Score-12 (FJS-12) as a tool to evaluate the 
outcome of hip and knee arthroplasty in a United Kingdom population.
Patients and Methods
All patients undergoing surgery between January and August 2014 were eligible for 
inclusion. Prospective data were collected from 205 patients undergoing total hip 
arthroplasty (THA) and 231 patients undergoing total knee arthroplasty (TKA). Outcomes 
were assessed with the FJS-12 and the Oxford Hip and Knee Scores (OHS, OKS) pre-
operatively, then at six and 12 months post-operatively. Internal consistency, convergent 
validity, effect size, relative validity and ceiling effects were determined.
Results
Data for the TKA and THA patients showed high internal consistency for the FJS-12 
(Cronbach α = 0.97 in TKAs, 0.98 in THAs). Convergent validity with the Oxford Scores was 
high (r = 0.85 in TKAs, r = 0.79 for THAs). From six to 12 months, the change was higher for 
the FJS-12 than for the OHS in THA patients (effect size d = 0.21 versus -0.03). Ceiling effects 
at one-year follow-up were low for the FJS-12 with just 3.9% (TKA) and 8.8% (THA) of 
patients achieving the best possible score.
Conclusion
The FJS-12 has strong measurement properties in terms of validity, internal consistency and 
sensitivity to change in TKA and THA patients. Low ceiling effects and good relative validity 
allow the monitoring of longer term outcomes, particularly in well-performing groups after 
total joint arthroplasty.
Cite this article: Bone Joint J 2017;99-B:218–24.
Total joint arthroplasty can achieve high levels
of pain relief, function and satisfaction for
patients with end-stage arthritis.1-3 In the
United Kingdom, almost 100 000 hip and knee
arthroplasty procedures are undertaken annu-
ally.4 The success of arthroplasty is assessed by
the long-term survival of the implant and by an
array of patient-reported outcome measures
(PROMs). Traditionally, joint-specific PROMs
have evaluated domains such as pain and func-
tion. Patient demographics and expectations of
‘reasonable’ post-operative function have
changed over the last 20 years: patients now
expect to function at ever-higher levels. As
such, the ceiling effects of current, commonly
used questionnaires may not reflect post-oper-
ative changes at this higher level of activity.
Perhaps the ultimate aim of joint replace-
ment surgery is for the patient to ‘forget’ that
they have had surgery, or for the outcome to be
so good that they become unaware of the (pre-
viously problematic) joint during daily life and
activities. The 12 question Forgotten Joint
Score (FJS-12)5 was introduced in 2012 with
the aim of assessing the patients’ ‘joint aware-
ness’. The authors of the score suggest this is
more representative of higher-level function
after surgery, as to be able to forget about the
joint requires the absence of pain and the abil-
ity to perform all desired functional tasks with-
out limitation. It is clearly important that an
outcome score is psychometrically validated
for use and known to accurately and reliably
assess the factors that it pertains to. Other
groups have used various language transla-
tions of the FJS-12 to evaluate outcomes in
series of arthroplasty patients.6-12 A few
authors have made limited attempts at psycho-
metric validation,6,8 in particular the reliability
of the score to achieve the same result has been
evaluated and re-test reliability has been
shown to be high, with intraclass correlation
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coefficients above 0.9.8,13,14 In general, previous studies
have only assessed post-operative time points.7-17 Only one
study, a French translation, has reported the pre-operative
data that is essential to infer change from pre-operative
score parameters and quantify operative success.6 To date,
detailed psychometric validation of the score in a native
English speaking population is lacking.
The aim of this study was to perform a comprehensive
psychometric evaluation and investigate the measurement
characteristics (dimensionality, validity and responsiveness)
of the English language version of the FJS-12 in total hip and
knee arthroplasty patients (THA and TKA). We also sought
to validate longitudinal data in contrast to the routinely used
Oxford Scores18,19 in a United Kingdom population.
Patients and Methods
Participants. Between January 2014 and August 2014, we
prospectively assessed 1108 patients who were to undergo
unilateral THA or TKA at a single NHS orthopaedic teach-
ing hospital. The study centre is the only hospital to receive
adult referrals in a predominantly urban regional popula-
tion of approximately 850 000 people. Ethical approval
was obtained for this project from the institutional review
board (11/AL/0079); and patients were recruited with
informed consent. All patient undergoing lower limb
arthroplasty were eligible for the study. For analysis we
required all three assessment time points, thus patients not
providing complete follow-up assessment data were
excluded. Individual patients could only be entered into the
analysis once to prevent bias, and the second operation in
cases of staged bilateral procedures was excluded. There
were no other exclusion criteria.
A total of 546 patients underwent TKA and 562 patients
underwent THA between January 2014 and August 2014.
Prospective data was available for 467 TKA patients and
466 THA patients. A total of 22 TKA patients and 25 THA
patients were excluded from the analysis as they underwent
bilateral surgery within the study period. As such 445 TKA
patients and 441 THA patients were eligible for the study.
Of these, 214 TKA patients and 236 THA patients were
excluded for not providing questionnaire data at all
three assessment time points (pre-operatively, 6-months
and 12-months). This resulted in 231 TKA and 205 THA
patients eligible for the study (Fig. 1). Excluded patients did
not differ significantly with regards to gender (TKA
p = 0.248 and THA p = 1.000) or age (TKA p = 0.198 and
THA p = 0.053). 
Demographic data is presented in Table I. The mean age
of THA cohort was 69.9 years with a 45.5% male and
55.5% female gender split. The mean age of the TKA
cohort was 67.6 years with a 41.5% male and 58.5%
female gender split.
Assessments took place at a pre-operative assessment
clinic and then by postal questionnaire at six and
Surgery between January 2014 and August 2014
TKA patients n = 546
THA patients n = 562
Included in the local joint register
TKA patients n = 467
THA patients n = 466
Left for eligibility
TKA patients n = 445
THA patients n = 441
Not in the study due to < 3 
assessment time points
TKA patients n = 214
THA patients n = 236
 Only baseline
 TKA patients n = 102 (22.9%)
 THA patients n = 118 (26.8%)
 Baseline and 6 mths
 TKA patients n = 65 (14.6%)
 THA patients n = 72 (16.3%)
 Baseline and 12 mths
 TKA patients n = 47 (10.6%)
 THA patients n = 46 (10.4%)
Inclusion in the analysis
TKA patients n = 231 (51.9%)
THA patients n = 2015 (46.5%)
Not in the study due to bilateral surgery
TKA patients n = 22
THA patients n = 25
Fig. 1
Patient selection flowchart. TKA, total knee arthroplasty; THA, total hip arthroplasty.
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12 months post-operatively. Sociodemographic data was
collated prior to surgery. The participants completed out-
come questionnaires independently. The FJS-12 question-
naire and the Oxford Knee or Hip Score (OKS or OHS)
were completed at all assessment time points. The short-
form (SF)-12 questionnaire20 was evaluated 12 months
post-operatively to place the joint specific scores in the con-
text of broader health domains.
Assessment instruments. The FJS-12 is a PROM which
assesses joint awareness during the activities of daily living
(for example, climbing stairs, walking for more than 15
minutes, in bed at night etc).5 It consists of 12 questions
with a five-point Likert response format.5 Item scores are
summed and linearly transformed to a 0 to 100 scale, a high
value reflecting the ability of the patient to forget about the
affected/replaced joint during the activities of daily living.
The OHS and OKS each consist of 12 questions which
assess the patient’s pain and function.18,19 Each item is
answered on a five point response scale ranging from 0 to 4,
and generates a summed total score ranging from 0 to 48,
where 0 indicates the worst possible outcome and 48 good
joint function.
The SF-12 Health survey is a 12-item quality of life ques-
tionnaire often used in large population health surveys.20
Each item is rated using a five-point Likert response format.
The transformed scores for each health domain reflect a
patient’s poor (0) to excellent (100) health status. Two sepa-
rate outputs are generated, a physical component summary
score (PCS) and mental component summary score (MCS).
Normative-based scoring is used for each component: the
population mean score is 50 (standard deviation (SD) 10).
Statistical analysis. Sample characteristics are given as
means with SD, ranges, and frequencies as appropriate.
Dimensionality was explored by means of Cronbach's
alpha, exploratory factor analysis (principal component
analysis), and confirmatory factor analysis based on poly-
choric correlations.21 Model-data fit for a one-factor solu-
tion was assessed using the following statistics and
thresholds for adequate fit: root mean square error of
approximation (RMSEA)22 < 0.10, Comparative Fit Index
(CFI)22 > 0.90, and Tucker-Lewis Index (TLI)23 > 0.90.
Convergent validity was assessed with Pearson correlations
between FJS-12 measures and OHS or OKS and the SF-12
Physical Component score. P-values of 0.05 or less were
considered as statistically significant. Discriminant validity
between the FJS-12 and the SF-12 MCS was assessed using
Pearson correlation. Correlation coefficients r > 0.50 were
considered as indicator of convergent validity and correla-
tions r < 0.35 as an indicator of divergent validity.24
Responsiveness was calculated by the change between
pre-operative and six-month follow-up time points, and
between the six and 12-month follow-up time points. This
is reported as effect size (ES) for the mean change in terms
of Cohen’s d. In addition, we calculated relative validity
(RV) for the FJS-12 and the Oxford Scores. RV (obtained
from the ratio of the F-statistics from a repeated measures
analysis of variance) gives the ratio of the sample sizes
required to detect a mean difference with either of the two
PROM instruments. The OKS and OHS Scores were used
as a reference measure at all three time points as they have
been proven to be responsive in the measurement of
change.
Floor and ceiling effects for the FJS-12 and the Oxford
Scores are given as the frequency of extreme scores (0 or
100 points for the FJS-12, 0 or 48 points for the Oxford
Scores) at the three different time points. In addition, we
give the percentage of patients scoring in the extreme 10%
of the scale range, similar to the analysis of Jette et al,25 to
provide information on the proportion of patients for
whom a minimal clinically important change would exceed
the range of the scale, and as a consequence would not be
measurable. Furthermore, we report the proportion of
missing responses on item-level as an indication of response
bias. Confirmatory factor analysis was conducted in the
software package R (R Foundation for Statistical Comput-
ing, Vienna, Austria) using the “lavaan” package.26 All
other statistical analyses were performed using SPSS 21.0
(IBM Corp., Armonk, New York).
Results
Dimensionality. Cronbach’s alpha coefficients showed high
internal consistency of the FJS-12 in both groups (α = 0.97
in TKA patients, α = 0.98 in THA patients). Exploratory
factor analysis of TKA and THA patients suggested a one-
factor model for the data, with a single factor explaining
75.6% of variance in TKA patients and 79.6% in THA
patients. Eigen values21 of further factors were all below
0.68 in both groups. Confirmatory factor analysis showed
good model-data fit for a one-factor solution in TKA
patients (CFI and TLI > 0.99, RMSEA 0.075) as well as
THA patients (CFI and TLI > 0.99, RMSEA 0.084). Stand-
ardised factor loadings ranged from 0.82 (item 12) to 0.96
(item 11) in TKA patients and from 0.85 (item 01) to 0.96
(item 11) in THA patients.
Table I. Patient characteristics at baseline (pre-operatively); total knee arthroplasty n = 231, total hip arthroplasty n = 205
Age (mean (SD), range) Gender (M:F) Side (left:right:missing)
Total knee arthroplasty 69.9 (9.6), 36 to 91 44.2%:55.8% (n = 102:n = 129) 52.4%:40.7%:6.9% (n = 121:n = 94:n = 16)
Total hip arthroplasty 67.6 (11.7), 31 to 92 41.5%:58.5% (n = 85:n = 120) 41.5%:58.5%:0% (n = 85:n = 120:n = 0)
SD, standard deviation
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Convergent and discriminant validity. To assess convergent
validity we correlated the FJS-12 with the Oxford Scores
and the SF-12 PCS. In TKA patients we found high correla-
tions for the OKS (r = 0.85) and the SF-12 PCS (r = 0.70).
Correlations in THA patients were slightly lower; r = 0.79
for the OHS and r = 0.67 for the SF-12 PCS. Discriminant
validity was better in the TKA group (correlation with SF-
12 MCS r = 0.23) than in the THA group (correlation with
SF-12 MCS r = 0.36).
Sensitivity to change over time. To measure the perfor-
mance of a score over time we analysed the data for all
time-intervals following surgery (Figs 2 and 3). Results are
detailed in Table II.
Pre-operative to six months post-operatively. Results for the
FJS-12 showed a large ES for change from pre-operative to
six-month follow-up in TKA patients (2.65) and in THA
patients (2.27). ES for the OKS and OHS were 1.95 for both
TKA patients and THA patients. RV for the FJS-12 was 2.27
in TKA patients and 2.01 in THA patients.
Six months to 12 months post-operatively. ES for the inter-
val between the six month and one-year time question-
naires were smaller for FJS-12 than for the first follow-up
(0.12 for TKA patients, 0.21 for THA patients). RV scores
decreased to 0.31 in TKA patients and to 0.04 in THA
patients. Results for the Oxford Scores showed an ES of
0.06 in TKA patients and -0.03 in THA patients.
Floor and ceiling effects. Pre-operatively, the FJS-12 showed
pronounced floor effects, with 15.6% of the TKA patients and
22.4% of the THA patients obtaining the minimum score of 0
points. At one-year follow-up, 3.9% of TKA patients and
8.8% of THA patients achieved the maximum score of 100
points. In contrast, the Oxford Scores did not show floor
effects pre-operatively; no patients obtained a score of 0 in
either group. At one-year follow-up the maximum score of 48
points was achieved in 0.9% of TKA patients and 14.1% of
THA patients.
In a more detailed analysis we defined the floor and ceil-
ing as being within the lowest and highest 10% of the score
range.25 This showed pronounced floor effects for the FJS-
12 pre-operatively (50.2% of TKA patients and 59.0% of
THA patients scored 0 to 10 points). The Oxford Scores
were not affected by floor effects. The ceiling effects for the
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Fig. 2a
Forgotten Joint Score (FJS-12) (a) and Oxford Knee Score (OKS) (b) pre-operatively and six and 12 months post-operatively (knee).
Fig. 2b
Table II. Means, standard deviations (SD) and responsiveness for the Forgotten Joint Score (FJS-12), Oxford Knee and Hip Scores (OKS and
OHS) and the Mental and Physical Component Scores (MCS, PCS)
Pre-operative 6 mths 1 yr Pre-operative to 6 mths 6 mths to 1 yr
Mean SD n Mean SD n Mean SD n ES RV ES RV
Knee FJS-12 11.5 11.6 231 42.1 30.0 231 45.7 31.2 231 2.65 2.27 0.12 0.31
OKS 20.7 7.4 231 35.0 8.8 231 35.5 9.3 231 1.95 1 0.06 1
MCS* - - - - - - 49.0 7.5 230 - - - -
PCS* - - - - - - 41.2 10.8 230 - - - -
Hip FJS-12 12.3 15.9 205 48.4 28.7 205 54.3 31.7 205 2.27 2.01 0.21 0.04
OHS 21.0 9.0 205 38.6 8.6 205 38.3 9.5 205 1.95 1 -0.03 1
MCS* - - - - - - 47.8 7.6 204 - - - -
PCS* - - - - - - 43.1 10.8 204 - - - -
* only administered at 12 months 
ES, effect size; RV, relative validity
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FJS-12 at one year post-operatively were approximately
half of those seen in the Oxford Scores at the same time
point (THA 18.5% FJS-12 versus 39.5% OHS, TKA
12.6% FJS-12 versus 25.5% OKS) (Table III).
Missing responses. Analysis of missing responses at a ques-
tionnaire item level highlighted generally high levels of
completion. Item completion was 98% for the FJS-12 in the
TKA cohort with the exception of question 12 (ability to
forget about the joint when taking part in sports activities)
which had missing responses of 12.1%. The same was
found in the THA cohort, with more than 97% item com-
pletion for each question except item 12 concerning sport-
ing activity, which was omitted in 19.8% of cases. The
Oxford Scores did not suffer from missing responses, with
more than 98% item completion across the 12 questions.
Discussion
‘Joint awareness’ is a distinct concept. Qualitative inter-
views with patients after knee arthroplasty have shown that
joint awareness is triggered at a cortical level by pain, func-
tional impairment, and associated sensations (such as
numbness, lack of sensation, ‘strange feelings’ with touch,
or weather-related sensations).27 Hudak et al28 define this
as ‘disrupted embodiment’, where the joint has become sep-
arated from the body. From a theoretical standpoint, a high
level of post-operative function may be related to the
patient's ability to ‘reunite’ the joint with the rest of the
body and to become ‘unaware’ of it in everyday life, akin to
the ‘normal’ condition of a ‘healthy’ joint.
With a variety of potential outcome assessment tools
available, it is essential that detailed psychometric evalua-
tion is available to inform choice of PROM instruments for
the assessment of specific study endpoints. The Consensus-
based Standards for the selection of health Measurement
Instruments criteria suggest that PROM instruments
should meet three main quality domains: reliability, validity
and responsiveness.29,30
In this native English speaking population, the FJS-12
shows strong measurement properties in terms of dimen-
sionality (reliability), convergent/discriminant validity and
sensitivity to change over time (responsibility).
The Oxford Scores are regularly used tools that have
been central to the development of arthroplasty outcomes.
They are valid and reliable, although they may suffer from
ceiling effects31,32 and may therefore lack the sensitivity to
capture relevant changes in patient function over longitudi-
nal time periods. As such there has been much interest in
developing more sensitive tools with which to assess the
outcome of arthroplasty.12,33,34
A major difference between the FJS-12 and the Oxford
Scores is the population in which they were designed. The
Oxford Scores were developed in pre-operative populations18,19
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Fig. 3a
Forgotten Joint Score (FJS-12) (a) and Oxford Hip Score (OHS) (b) pre-operatively and six and 12 months post-operatively (hip).
Fig. 3a
Table III. Floor and ceiling effects of total knee arthroplasty and total hip arthroplasty outcome measures
Pre-operative (%) 6 mths (%) 1 yr (%)
Floor Floor (10%) Ceiling Ceiling (10%) Floor Floor (10%) Ceiling Ceiling (10%) Floor Floor (10%) Ceiling Ceiling (10%) 
Knee FJS-12 15.6 50.2 0.0 0.0 3.9 14.3 3.5 9.1 3.0 12.6 3.9 12.6
OKS 0.0 0.9 0.0 0.0 0.0 0.0 0.9 19.0 0.0 0.0 0.9 25.5
Hip FJS-12 22.4 59.0 0.0 0. 2.4 10.2 3.9 9.8 2.0 8.3 8.8 18.5
OHS 0.0 1.0 0.5 1.0 0.0 1.0 7.3 33.7 0.0 0.0 14.1 39.5
FJS-12, Forgotten Joint Score; OKS, Oxford Knee Score; OHS, Oxford Hip Score
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and reflect the symptom state at that time point. In con-
trast, the FJS-12 was designed in a post-operative popula-
tion and the construct reflects the symptom state after joint
replacement surgery. This may explain the respective floor
and ceiling effects of the scores. We have shown that the
Oxford Scores are more responsive in reflecting the initial
change between the pre-operative presentation and six
months post-operatively, but less so for the change between
six- and 12-month follow-up. As such, the FJS-12 had
higher effect sizes than the Oxford Scores covering this time
period, but lower relative validity. This is directly related to
the floor effect of the FJS-12 pre-operatively which results
in a low SD of the score at that time point. As the SD is the
denominator of Cohen’s d, the effect sizes are inflated. By
contrast, for the later follow-up period (six to 12 months),
the FJS-12 outperformed the Oxford Scores in both THA
and TKA cohorts. A recent Danish study also found that at
later follow-up time points, the OKS has a higher ceiling
effect than the FJS-12.14
To date, this is the most comprehensive evaluation of the
psychometric properties of the FJS-12. Others have evalu-
ated selected measurement characteristics in various
cohorts and languages. Matsumoto et al7 found good con-
vergent validity in a Japanese cohort of hip arthroplasty
patients between the FJS-12 and the Western Ontario
McMaster Universities Osteoarthritis index (WOMAC)
(r = 0.53) and a culture-specific hip outcome instrument,
the Japanese Orthopaedic Association Hip Disease Evalua-
tion Questionnaire (r = 0.63). Thompson et al8 found a very
high test-retest reliability for the FJS-12 (r = 0.97) in an
Australian knee arthroplasty cohort. In this study, conver-
gent validity was high with the WOMAC total score
(r = 0.70) and Knee injury and Osteoarthritis Outcome
Score (KOOS) and Quality of Life, Pain and activities of
daily living scores (r = 0.65). They further reported less ceil-
ing effect in the FJS-12 compared with the WOMAC and
KOOS questionnaires. Similarly, Giesinger et al11 indicated
superior responsiveness to change for the FJS-12 between
one and two year follow-ups compared with the WOMAC
and the Knee Society Score, using data from a Swiss clinical
trial in knee arthroplasty patients. These three studies
broadly support the results of this evaluation, where the
FJS-12 showed strong convergent validity with the OKS
and OHS and the physical component score of the SF-12.
Reassuringly, the association with the mental health com-
ponent of the SF-12 was low, highlighting appropriate
divergent validity.
We report a lesser improvement in the FJS-12 from the
pre-operative to one-year post-operative scores compared
with Thienpont et al,6 who used a French translation of the
score in a Belgian population. In their study of 75 THA and
75 TKA patients, there was a more pronounced ceiling effect
post-operatively but less of a floor effect pre-operatively.
This may highlight a variation in cultural response in inter-
national samples, or may also be due to higher rates of
missing responses for individual FJS-12 items in that study.
Reassuringly the baseline and post-operative scores in
our sample, as measured by the Oxford Scores, are compa-
rable with data from the United Kingdom National Joint
Registry,35 suggesting our cohort data to be reflective of the
population of the United Kingdom.
In our study, missing responses for individual FJS-12
items were below 3% for 11 out of 12 items in both hip and
knee samples. A single question, that of joint awareness
during sports, was less well reported. While this suggests
that a modest proportion of United Kingdom arthroplasty
patients do not consider a question on sporting participa-
tion to be applicable, over 80% did respond, perhaps
reflecting the evolving expectation of higher level function
of patients after joint arthroplasty.
The strengths of this study are its prospective design, a
well-defined cohort of patients and the incorporation of
pre-operative data. A potential limitation is that this
study has a limited follow-up period of 12 months,
although this is the typical time period reported in clini-
cal outcome evaluations and in arthroplasty joint regis-
tries. The range of comparator outcome metrics is
somewhat restricted. A further limitation is the percent-
age of patients with missing follow-up assessment data at
six months or 12 months that were not included in our
analysis. While this does not affect the validity of the
analyses presented here, it may limit this data in terms of
absolute clinical outcome scores.
The current study and previous work suggest that the
FJS-12 has the benefits of improved responsiveness and
reduced ceiling effects. The low ceiling effects of the FJS-
12 may offer advantages when evaluating high performing
groups or in powering clinical trials. We suggest that joint
awareness could be seen as a relevant outcome domain in
its own right, and complementary to questionnaires that
assess pain and physical function. It may be that a battery
of scores is required to evaluate the full impact of joint
surgery from the point of view of the patient. As such, we
suggest future studies evaluate qualitative aspects of the
patient’s conceptualisation of ‘joint awareness’ and inves-
tigate the relative importance of joint awareness com-
pared with joint-specific outcome domains (such as pain
and function). Such questions could also be investigated
quantitatively using structural equation modelling tech-
niques. It may also be interesting to validate the FJS-12 for
other joint conditions to investigate the potential of the
score in patient groups where a good outcome following a
surgical or conservative intervention is likely to be
achieved, for example the conservative management of
sports injuries.
The FJS-12 demonstrates strong measurement properties
in terms of validity, uni-dimensionality and sensitivity to
change in both hip and knee arthroplasty patients. Low
ceiling effects and good relative validity suggest that this
score may be beneficial for monitoring outcomes over the
long-term in patient cohorts expected to achieve high levels
of function, or for powering clinical trials.
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Take home message:
- This paper validates a new outcome score that assesses the
patient’s awareness of their joint replacement in a United
Kingdom population. 
- Strong measurement properties suggest this to be an interesting avenue
for further research into patient outcomes, particularly in differentiating
outcomes in highly performing patient groups.
Author contributions:
D. F. Hamilton: Study design, Data analysis, Manuscript preparation/editing. 
F. L. Loth: Data analysis, Manuscript preparation/editing.
J. M. Giesinger: Study design, Data analysis, Manuscript preparation/editing.
K. Giesinger: Study design, Manuscript editing.
D. J. Macdonald: Study design, Data collection, Manuscript editing. 
J. T. Patton: Study design, Manuscript editing.
A. H. R. W. Simpson: Study design, Manuscript editing.
C. R. Howie: Study design, Manuscript editing.
The author or one or more of the authors have received or will receive benefits
for personal or professional use from a commercial party related directly or
indirectly to the subject of this article.
This is an open-access article distributed under the terms of the Creative Com-
mons Attributions licence (CC-BY-NC), which permits unrestricted use, distribu-
tion, and reproduction in any medium, but not for commercial gain, provided
the original author and source are credited.
This article was primary edited by E. Moulder and first proof edited by
A. C. Ross.
References
1. Baker PN, van der Meulen JH, Lewsey J, Gregg PJ, National Joint Registry
for England and Wales. The role of pain and function in determining patient satis-
faction after total knee replacement. Data from the National Joint Registry for Eng-
land and Wales. J Bone Joint Surg [Br] 2007;89-B:893–900.
2. Hamilton DF, Lane JV, Gaston P, et al. What determines patient satisfaction with
surgery? A prospective cohort study of 4709 patients following total joint replace-
ment. BMJ Open 2013;3:e002525.
3. Hamilton DF, Burnett R, Patton JT, et al. Implant design influences patient out-
come after total knee arthroplasty: a prospective double-blind randomised controlled
trial. Bone Joint J 2015;97-B:64–70.
4. No authors listed. National Joint Registry. http://www.njrcentre.org.uk (date last
accessed 19 October 2016).
5. Behrend H, Giesinger K, Giesinger JM, Kuster MS. The “forgotten joint” as the
ultimate goal in joint arthroplasty: validation of a new patient-reported outcome
measure. J Arthroplasty 2012;27:430–436.
6. Thienpont E, Vanden Berghe A, Schwab PE, Forthomme JP, Cornu O. Joint
awareness in osteoarthritis of the hip and knee evaluated with the ‘Forgotten Joint’
Score before and after joint replacement. Knee Surg Sports Traumatol Arthrosc
2016;24:3346–3351.
7. Matsumoto M, Baba T, Homma Y, et al. Validation study of the Forgotten Joint
Score-12 as a universal patient-reported outcome measure. Eur J Orthop Surg Trau-
matol 2015;25:1141–1145.
8. Thompson SM, Salmon LJ, Webb JM, Pinczewski LA, Roe JP. Construct Valid-
ity and Test Re-Test Reliability of the Forgotten Joint Score. J Arthroplasty
2015;30:1902–1905.
9. Giesinger K, Hamilton DF, Jost B, Holzner B, Giesinger JM. Comparative
responsiveness of outcome measures for total knee arthroplasty. Osteoarthritis Car-
tilage 2014;22:184–189.
10. Thienpont E, Zorman D. Higher forgotten joint score for fixed-bearing than for
mobile-bearing total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc
2016;24:2641–2645.
11. Thienpont E, Opsomer G, Koninckx A, Houssiau F. Joint awareness in different
types of knee arthroplasty evaluated with the Forgotten Joint score. J Arthroplasty
2014;29:48–51.
12. Bell SW, Stoddard J, Bennett C, London NJ. Accuracy and early outcomes in
medial unicompartmental knee arthroplasty performed using patient specific instru-
mentation. Knee 2014;21:S33–S36.
13. Shadid MB, Vinken NS, Marting LN, Wolterbeek N. The Dutch version of the
Forgotten Joint Score: test-retesting reliability and validation. Acta Orthop Belg
2016;82:112–118.
14. Thomsen MG, Latifi R, Kallemose T, et al. Good validity and reliability of the for-
gotten joint score in evaluating the outcome of total knee arthroplasty. Acta Orthop
2016;87:280–285.
15. Fabre-Aubrespy M, Ollivier M, Pesenti S, Parratte S, Argenson JN. Unicom-
partmental Knee Arthroplasty in Patients Older Than 75 Results in Better Clinical Out-
comes and Similar Survivorship Compared to Total Knee Arthroplasty. A Matched
Controlled Study. J Arthroplasty 2016;31:2668–2671.
16. Thomsen MG, Latifi R, Kallemose T, Husted H, Troelsen A. Does knee aware-
ness differ between different knee arthroplasty prostheses? A matched, case-control,
cross-sectional study. BMC Musculoskelet Disord 2016;17:141.
17. Nielsen KA, Thomsen MG, Latifi R, et al. Does post-operative knee awareness
differ between knees in bilateral simultaneous total knee arthroplasty? Predictors of
high or low knee awareness. Knee Surg Sports Traumatol Arthrosc 2016;24:3352–
3358.
18. Dawson J, Fitzpatrick R, Murray D, Carr A. Questionnaire on the perceptions of
patients about total knee replacement. J Bone Joint Surg [Br] 1998;80-B:63–69.
19. Dawson J, Fitzpatrick R, Carr A, Murray D. Questionnaire on the perceptions of
patients about total hip replacement. J Bone Joint Surg [Br] 1996;78-B:185–190.
20. Ware J Jr, Kosinski M, Keller SD. A 12-item Short-Form Health survey: construc-
tion of scales and preliminary tests of reliability ad validity. Med Care 1996;34:220–
233.
21. Fayers P, Hays R. Assessing Quality of Life in Clinical Trials - Methods and practice.
Oxford: Oxford University Press, 2005.
22. Browne MW, Cudeck R. Alternative Ways of Assessing Model Fit. Sociological
Methods & Research 1992;21:230–258.
23. Kline RB. Principles and practice of structural equation modeling. Second ed. New
York: The Guilford Press, 2005.
24. Juniper EF, Guyatt GH, Jaeschke R. How to develop and validate a new health-
related instrument. In: Spilker B, ed. Quality of Life and Pharmacoeconomics in Clini-
cal Trials. Philadelphia: Lippincott-Raven Publishers, 1996:49–56.
25. Jette AM, Haley SM, Tao W, et al. Prospective evaluation of the AM-PAC-CAT in
outpatient rehabilitation settings. Phys Ther 2007;87:385–398.
26. Rosseel Y. Iavaan: An R Package for Structural Equation Modeling. Journal of Sta-
tistical Software 2012;48:1–36.
27. Lewis S, Price M, Dwyer KA, et al. Development of a scale to assess performance
following primary total knee arthroplasty. Value Health 2014;17:350–359.
28. Hudak PL, McKeever PD, Wright JG. Understanding the meaning of satisfaction
with treatment outcome. Med Care 2004;42:718–725.
29. Mokkink LB, Terwee CB, Patrick DL, et al. The COSMIN checklist for assessing
the methodological quality of studies on measurement properties of health status
measurement instruments: an international Delphi study. Qual Life Res 2010;19:539–
549.
30. Mokkink LB, Prinsen CA, Bouter LM, Vet HC, Terwee CB. The COnsensus-based
Standards for the selection of health Measurement INstruments (COSMIN) and how
to select an outcome measurement instrument. Braz J Phys Ther 2016;20:105–113.
31. Terwee CB, Mokkink LB, Knol DL, et al. Rating the methodological quality in sys-
tematic reviews of studies on measurement properties: a scoring system for the COS-
MIN checklist. Qual Life Res 2012;21:651–657.
32. Ostendorf M, van Stel HF, Buskens E, et al. Patient-reported outcome in total hip
replacement. A comparison of five instruments of health status. J Bone Joint Surg [Br]
2004;86-B:801–808.
33. Dawson J, Beard DJ, McKibbin H, et al. Development of a patient-reported out-
come measure of activity and participation (the OKS-APQ) to supplement the Oxford
knee score. Bone Joint J 2014;96-B:332–338.
34. Roos EM, Roos HP, Lohmander LS, Ekdahl C, Beynnon BD. Knee Injury and
Osteoarthritis Outcome Score (KOOS)--development of a self-administered outcome
measure. J Orthop Sports Phys Ther 1998;28:88–96.
35. The NJR Editorial Board. 12th Annual Report. National Joint Registry for England,
Wales, Northern Ireland and the Isle of Man 2015. http://www.njrcentre.org.uk/njr-
centre/Reports,PublicationsandMinutes/Annualreports/tabid/86/Default.aspx (date
last accessed 19 October 2016).
